<DOC>
	<DOCNO>NCT02475369</DOCNO>
	<brief_summary>The purpose protocol conduct pilot study investigate whether pancreatic enzyme supplementation improve symptom individual celiac disease suffer persistent symptom despite gluten free diet . This protocol specifically aim : 1 . Evaluate efficacy pancreatic enzyme supplementation reduction gastrointestinal symptom patient celiac disease gluten free diet . 2 . Assess ability fecal elastase level predict response pancreatic enzyme supplementation patient celiac disease gluten free diet .</brief_summary>
	<brief_title>Pancreatic Enzyme Supplementation Celiac Disease</brief_title>
	<detailed_description />
	<mesh_term>Celiac Disease</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Biopsy proven celiac disease . Age 1880 . Ongoing symptom define CeDGSRS score great 3 run period . Subject must follow gluten free diet . tTG &lt; 40 unit screen . Taking prescription counter enzyme supplement 1 month prior enrollment . Pregnant , breastfeed planning pregnancy . Woman use acceptable method contraception include . Acceptable method contraception include oral hormonal contraceptive , implant hormonal contraceptive , diaphragm spermicide , condom , intrauterine device , abstinence , male partner vasectomy . Patients pork allergy unwilling consume pork product . English proficiency unsuitable completion survey . Known severe pancreatic disease . Known history prior cancer ( except squamous basal cell skin cancer ) . Patients lactose intolerance unable tolerate minimum 1oz ( 2 tablespoon ) whole milk per day . Clinically significant abnormality safety lab value ( i.e . CBC BMP ) screening may impact subject safety scientific integrity study . Other know active GI condition include limited inflammatory bowel disease , small intestine bacterial overgrowth , obvious FODMAP intolerance . History major gastrointestinal surgery appendectomy cholecystectomy . Comorbid condition opinion investigator would interfere subject 's participation study would confound result study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>pancreatic enzyme supplementation</keyword>
</DOC>